Skip Navigation


Rheumatology Advance Access originally published online on September 1, 2007
Rheumatology 2007 46(10):1628-1629; doi:10.1093/rheumatology/kem208
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/10/1628    most recent
kem208v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dunkley, L.
Right arrow Articles by Gough, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunkley, L.
Right arrow Articles by Gough, A.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: A case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy

L. Dunkley, M. Green and A. Gough

Department of Rheumatology, Harrogate Health Care NHS Trust, Lancaster Park Road, Harrogate HG2 7SX, UK

Correspondence to: Dr Mike Green, Consultant Rheumatologist, Harrogate Health Care NHS Trust, Lancaster Park Road, Harrogate HG2 7SX, UK. E-mail: mike.green@hdft.nhs.uk

The first 10% of the full text of this article appears below.

SIR, We wish to respond to the recent case report of a patient with mixed connective tissue disease whose Raynaud's phenomenon responded to Rituximab therapy [1]. We would like to report a patient with undifferentiated, anti-nuclear antibody (ANA)-positive, connective tissue disease whose Raynaud's phenomenon did not respond to Rituximab.

A 32-yr-old woman presented in 2004 with severe triphasic Raynaud's, livedo, large joint arthralgia and a strongly positive ANA (nucleolar staining, 1: 1600 titre). She . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?